Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nabriva Therapeutics Plc (NBRV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 4,012,374 $5,858 -6% 1.51%
2.
Vivo Capital

Albert Cha And Frank Kung

6,619,190 $9,664 1.23%
3.
OrbiMed Advisors

Samuel Isaly

4,644,600 $6,781 0.12%
4.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,600,000 $2,336 -12% 0.11%
5.
MSDC Management

Marc Lisker, Glenn Fuhrman And John Phelan

50,000 $73 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.31 53,000 Director 53,000 2018-12-24 Filing
$2.75 14,500 Director 47,640 2018-07-31 Filing
$2.75 36,000 Director 36,000 2018-07-31 Filing
$3.82 10,000 Officer 22,740 2018-06-23 Filing
$3.73 5,500 Officer 5,500 2018-06-22 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.52 3,429 Large Shareholder 2,334,128 2017-09-14 Filing
$8.54 22,721 Large Shareholder 2,337,557 2017-09-13 Filing
$8.63 10,458 Large Shareholder 2,360,278 2017-09-12 Filing
$9.50 639 Large Shareholder 2,370,735 2017-08-31 Filing
$10.50 2,013 Large Shareholder 2,371,374 2017-08-08 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 4,703,720 $6,867 0.96%
2. 100,000 $146 0.03%
3. 242,582 $354 0.02%
4. 103,550 $151 0.01%
5. 46,739 $68 0%